Rationale for Use of Combination Therapy in Rosacea.
Administration, Cutaneous
Adrenergic alpha-Agonists
/ administration & dosage
Adult
Aftercare
/ methods
Anti-Inflammatory Agents
/ administration & dosage
Color
Combined Modality Therapy
/ methods
Dermatology
/ methods
Diagnostic Errors
/ prevention & control
Drug Therapy, Combination
/ methods
Female
Humans
Ivermectin
/ administration & dosage
Laser Therapy
/ methods
Male
Middle Aged
Patient Education as Topic
/ standards
Practice Guidelines as Topic
Rosacea
/ diagnosis
Skin
/ drug effects
Skin Pigmentation
Societies, Medical
/ standards
Treatment Outcome
United States
Journal
Journal of drugs in dermatology : JDD
ISSN: 1545-9616
Titre abrégé: J Drugs Dermatol
Pays: United States
ID NLM: 101160020
Informations de publication
Date de publication:
01 10 2020
01 10 2020
Historique:
entrez:
7
10
2020
pubmed:
8
10
2020
medline:
8
6
2021
Statut:
ppublish
Résumé
Rosacea is a chronic skin condition characterized by primary and secondary manifestations affecting the centrofacial skin. The primary diagnostic phenotypes for rosacea are fixed centrofacial erythema with periodic intensification, and phymatous changes. Major phenotypes, including papules and pustules, flushing, telangiectasia, and ocular manifestations, may occur concomitantly or independently with the diagnostic features. The phenotypes of rosacea patients may evolve between subtypes and may require multiple treatments concurrently to be effectively managed. We report the proceedings of a roundtable discussion among 3 dermatologists experienced in the treatment of rosacea and present examples of rosacea treatment strategies that target multiple rosacea symptoms presenting in individual patients. Three hypothetical cases describing patients representative of those commonly seen by practicing dermatologists were developed. A roundtable discussion was held to discuss overall and specific strategies for treating rosacea based on the cases. With few exceptions, the dermatologists recommended combination therapy targeting each manifestation of rosacea for each case. These recommendations are in agreement with the current American Acne and Rosacea Society treatment guidelines for rosacea and are supported by several studies demonstrating beneficial results from combining rosacea treatments. Rosacea is an evolving condition; care should take into account all clinical signs and symptoms of rosacea that are present in an individual patient, understanding that symptoms may change over time, and utilize combination therapy when applicable to target all rosacea symptoms.
J Drugs Dermatol. 2020;19(10): 929-934. doi:10.36849/JDD.2020.5367.
Sections du résumé
BACKGROUND
Rosacea is a chronic skin condition characterized by primary and secondary manifestations affecting the centrofacial skin. The primary diagnostic phenotypes for rosacea are fixed centrofacial erythema with periodic intensification, and phymatous changes. Major phenotypes, including papules and pustules, flushing, telangiectasia, and ocular manifestations, may occur concomitantly or independently with the diagnostic features. The phenotypes of rosacea patients may evolve between subtypes and may require multiple treatments concurrently to be effectively managed. We report the proceedings of a roundtable discussion among 3 dermatologists experienced in the treatment of rosacea and present examples of rosacea treatment strategies that target multiple rosacea symptoms presenting in individual patients.
METHODS
Three hypothetical cases describing patients representative of those commonly seen by practicing dermatologists were developed. A roundtable discussion was held to discuss overall and specific strategies for treating rosacea based on the cases.
RESULTS/DISCUSSION
With few exceptions, the dermatologists recommended combination therapy targeting each manifestation of rosacea for each case. These recommendations are in agreement with the current American Acne and Rosacea Society treatment guidelines for rosacea and are supported by several studies demonstrating beneficial results from combining rosacea treatments.
CONCLUSIONS
Rosacea is an evolving condition; care should take into account all clinical signs and symptoms of rosacea that are present in an individual patient, understanding that symptoms may change over time, and utilize combination therapy when applicable to target all rosacea symptoms.
J Drugs Dermatol. 2020;19(10): 929-934. doi:10.36849/JDD.2020.5367.
Identifiants
pubmed: 33026776
pii: S1545961620P0929X
doi: 10.36849/JDD.2020.5367
doi:
Substances chimiques
Adrenergic alpha-Agonists
0
Anti-Inflammatory Agents
0
Ivermectin
70288-86-7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM